HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan

  • Scheme Category:  
  • Equity Scheme >  
  • Sectoral/Thematic Funds
NAV: ₹ 19.848 ↓ -0.2%
[as on 15 May, 2026]

NAV chart

SMA (Simple Moving Average)

  • 50 SMA
  • 100 SMA
  • 200 SMA
  • 400 SMA

Returns

CAGR returns till date

CAGR returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan and its peers as on 15 May, 2026
NameYTD1D1W1M3M1Y3Y5Y7Y10Y
HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan 12.43% -0.2% 0.66% 8.58% 12.28% 20.95%----
SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH -6.67% -0.05% -3.03% -0.26% -3.35% -7.19% 10.75% 15.93% 15.72% 15.48%
SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth -7.57% -0.37% -2.86% -2.6% -5.76% -3.15% 11.25% 11.73% 13.07% 12.79%
SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH 9.97% -0.27% 0.86% 7.97% 10.76% 11.43% 27.41% 17.15% 23.53% 14.07%
SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH 1.98% -0.37% -2.08% 4.58% 3.45% 3.03% 20.94% 21% 20.18% 16.63%
SBI PSU Fund - DIRECT PLAN - GROWTH 3.54% -0.78% -2.01% -1.68% -1.94% 13.2% 31.31% 26.32% 21.19% 16.61%

Discrete returns (yearly)

Year2016201720182019202020212022202320242025
Returns-------- 52.37% 1.73%

Discrete returns (monthly)

MonthJul 2025Aug 2025Sep 2025Oct 2025Nov 2025Dec 2025Jan 2026Feb 2026Mar 2026Apr 2026
Returns 5.33% -1.45% -1.45% 2.16% 1.22% -1.38% -4.65% 6.99% -4.36% 7.84%

Returns from spefic dates

DescriptionCAGR returns from 26 Sep 2024 (Nifty 50 2024 high)
Returns 13.14%

Portfolio

Asset allocation

EquityDebtRealestateCommoditiesCash & Equivalents
98.52% 0.00% (Arbitrage: 0.00%) 0.00% 0.00% 1.48%

Equity

NameSymbol / ISINSectorWeight %
Sun Pharmaceutical Industries Ltd.SUNPHARMA (INE044A01036)Pharmaceuticals & Biotechnology10.20%
Divis Laboratories Ltd.DIVISLAB (INE361B01024)Pharmaceuticals & Biotechnology8.20%
Glenmark Pharmaceuticals Ltd.GLENMARK (INE935A01035)Pharmaceuticals & Biotechnology6.78%
Lupin Ltd.LUPIN (INE326A01037)Pharmaceuticals & Biotechnology6.65%
Alkem Laboratories Ltd.ALKEM (INE540L01014)Pharmaceuticals & Biotechnology5.99%
Max Healthcare Institute LimitedMAXHEALTH (INE027H01010)Healthcare Services5.96%
Aster DM Healthcare LimitedASTERDM (INE914M01019)Healthcare Services5.70%
Ipca Laboratories Ltd.IPCALAB (INE571A01038)Pharmaceuticals & Biotechnology5.16%
Acutaas Chemicals LimitedACUTAAS (INE00FF01025)Pharmaceuticals & Biotechnology4.39%
Anthem Biosciences LimitedANTHEM (INE0CZ201020)Pharmaceuticals & Biotechnology4.29%
Fortis Healthcare LimitedFORTIS (INE061F01013)Healthcare Services3.49%
Krishna Institute Of Medical Sciences LimitedKIMS (INE967H01025)Healthcare Services3.10%
Laurus Labs Ltd.LAURUSLABS (INE947Q01028)Pharmaceuticals & Biotechnology2.76%
Metropolis Healthcare Ltd.METROPOLIS (INE112L01020)Healthcare Services2.37%
Torrent Pharmaceuticals Ltd.TORNTPHARM (INE685A01028)Pharmaceuticals & Biotechnology2.34%
Eris Lifesciences LtdERIS (INE406M01024)Pharmaceuticals & Biotechnology2.24%
Vijaya Diagnostic Centre LimitedVIJAYA (INE043W01024)Healthcare Services2.13%
Sai Life Sciences LimitedSAILIFE (INE570L01029)Pharmaceuticals & Biotechnology2.09%
Shilpa Medicare LtdSHILPAMED (INE790G01031)Pharmaceuticals & Biotechnology1.91%
Global Health LimitedMEDANTA (INE474Q01031)Healthcare Services1.88%
Dr. Lal Path Labs LtdLALPATHLAB (INE600L01024)Healthcare Services1.57%
Neuland Laboratories LimitedNEULANDLAB (INE794A01010)Pharmaceuticals & Biotechnology1.54%
Wockhardt Ltd.WOCKPHARMA (INE049B01025)Pharmaceuticals & Biotechnology1.54%
Jubilant Pharmova LimitedJUBLPHARMA (INE700A01033)Pharmaceuticals & Biotechnology1.31%
Thyrocare Technologies Ltd.THYROCARE (INE594H01019)Healthcare Services1.27%
Rubicon Research LimitedRUBICON (INE506V01022)Pharmaceuticals & Biotechnology1.24%
Gland Pharma Ltd.GLAND (INE068V01023)Pharmaceuticals & Biotechnology1.07%
BAJAJ HEALTHCARE LIMITEDBAJAJHCARE (INE411U01027)Pharmaceuticals & Biotechnology0.83%
Laxmi Dental LimitedLAXMIDENTL (INE0WO601020)Healthcare Equipment & Supplies0.52%
Portfolio data is as on date 31 March, 2026

NAV history

HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan - 30 days NAV (Net asset value) history

DateNAV% change
15 May, 202619.848 -0.2%
14 May, 202619.888 1.6%
13 May, 202619.575 0.47%
12 May, 202619.484 -1.77%
11 May, 202619.835 0.6%
8 May, 202619.717 0.45%
7 May, 202619.628 0.31%
6 May, 202619.567 1.69%
5 May, 202619.242 0.23%
4 May, 202619.198 2.04%
30 April, 202618.814 -0.01%
29 April, 202618.815 0.27%
28 April, 202618.764 -0.4%
27 April, 202618.839 2.33%
24 April, 202618.41 -0.96%
23 April, 202618.589 0.74%
22 April, 202618.452 0.41%
21 April, 202618.377 0.07%
20 April, 202618.364 0.01%
17 April, 202618.363 0.39%
16 April, 202618.292 0.07%
15 April, 202618.279 1.83%
13 April, 202617.951 -0.49%
10 April, 202618.04 0.67%
9 April, 202617.92 0.96%
8 April, 202617.75 1.78%
7 April, 202617.439 0.4%
6 April, 202617.37 0.58%
2 April, 202617.269 -1.01%
1 April, 202617.446

FAQ (Frequently asked questions)

  • What is latest/current NAV/price of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The latest NAV of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan is 19.848 as on 15 May, 2026.
  • What are YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The YTD (year to date) returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 12.43% as on 15 May, 2026.
  • What are 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan?
    The 1 year returns of HDFC Pharma and Healthcare Fund - Growth Option - Direct Plan are 20.95% as on 15 May, 2026.